G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

Who May Qualify: - Patient must be a legal adult who has reached full skeletal maturity. - Patient must be treated for one of the following indications: - Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis - Rheumatoid arthritis - Correction of functional deformity - Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques - Revision procedures where other treatment or devices have failed - Patient must be able and willing to complete the protocol required follow-up visits. - Patient must be able and willing to sign the Institutional Review Board or Ethics Committee (IRB/EC) approved willing to sign a consent form. Who Should NOT Join This Trial: - Patient presents with osteoporosis, which in the opinion of the Principal Investigator, may limit the subject's ability to support total hip arthroplasty using the study device. - Patient has a metabolic disorder that may impair bone formation. - Patient has osteomalacia. - Patient has distant foci of infections which may spread to the implant site or patient with infection, sepsis or osteomyelitis. - Patient has rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram. - Patient has a vascular insufficiency, muscular atrophy, or neuromuscular disease - Patient is a prisoner. - Patient is a current alcohol or drug abuser. - Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions. - Patient is pregnant. Always talk to your doctor about whether this trial is right for you.